LONG-TERM LINEZOLID TREATMENT IN A YOUNG CHILD WITH EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS

被引：26

作者：

Schaaf, H. Simon ^{[1
,2
]}

Willemse, Marianne ^{[3
]}

Donald, Peter R. ^{[1
,2
]}

机构：

[1] Univ Stellenbosch, Dept Paediat & Child Hlth, Cape Town, South Africa

[2] Tygerberg Childrens Hosp, Cape Town, South Africa

[3] Prov Govt Western Cape Brooklyn Chest Hosp, Dept Hlth, Cape Town, South Africa

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2009年 / 28卷 / 08期

关键词：

extensively drug-resistant; tuberculosis; treatment; linezolid; MYCOBACTERIUM-TUBERCULOSIS; EFFICACY;

D O I：

10.1097/INF.0b013e31819bc491

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Treatment of extensively drug-resistant tuberculosis (XDR-TB) is a challenge. We describe a Young child with pulmonary XDR-TB who did not respond to all aggressive multidrug-resistant TB treatment regimen, but was cured with linezolid in combination with other reserve antituberculous drugs. No serious adverse events were observed during 19 months of treatment for XDR-TB.

引用

页码：748 / 750

页数：3

共 10 条

[1] In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs [J].

Alcalá, L ;

Ruiz-Serrano, MJ ;

Turégano, CPF ;

Garcia de Viedma, D ;

Díaz-Infantes, M ;

Marín-Arriaza, M ;

Bouza, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) :416-417

[2] Intravenous linezolid administered orally: A novel desensitization strategy [J].

Cawley, MJ ;

Lipka, O .

PHARMACOTHERAPY, 2006, 26 (04) :563-568

[3]

Condos Rany, 2008, Chest, V134, P187, DOI 10.1378/chest.07-1988

[4]

Donald PR, 2001, SCAND J INFECT DIS, V33, P466, DOI 10.1080/00365540152029954

[5] In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates [J].

Erturan, Z ;

Uzun, M .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 (01) :78-80

[6] Linezolid for the treatment of multidrug-resistant tuberculosis [J].

Fortún, J ;

Martín-Dávila, P ;

Navas, E ;

Pérez-Elías, MJ ;

Cobo, J ;

Tato, M ;

De la Pedrosa, EGG ;

Gómez-Mampaso, E ;

Moreno, S .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (01) :180-185

[7] Use of linezolid in children [J].

Kaplan, SL .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (09) :870-872

[8] ANTITUBERCULOSIS ACTIVITY OF CLARITHROMYCIN [J].

LUNAHERRERA, J ;

REDDY, VM ;

DANELUZZI, D ;

GANGADHARAM, PRJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) :2692-2695

[9] Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis [J].

Park, I-Nae ;

Hong, Sang-Bum ;

Oh, Yeon-Mok ;

Kim, Mi-Na ;

Lim, Chae-Man ;

Lee, Sang Do ;

Koh, Younsuck ;

Kim, Woo Sung ;

Kim, Dong Soon ;

Kim, Won Dong ;

Shim, Tae Sun .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (03) :701-704

[10] Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB) - a report of ten cases [J].

von der Lippe, B ;

Sandven, P ;

Brubakk, O .

JOURNAL OF INFECTION, 2006, 52 (02) :92-96

← 1 →